Zobrazeno 1 - 10
of 34
pro vyhledávání: '"HG Ahuja"'
Publikováno v:
Blood. 78:3259-3268
The retinoblastoma-susceptibility (Rb) gene is an antioncogene that is frequently altered in retinoblastomas, sarcomas, and some epithelial tumors. We examined the structure of the Rb gene by Southern blotting in 215 cases of leukemias and lymphomas
Autor:
A Foti, S. L. Allen, P. Schulman, M. W. Schuster, M. Bar-Eli, HG Ahuja, Martin J. Cline, Prasad Koduru
Publikováno v:
Scopus-Elsevier
A patient with typical Philadelphia chromosome (Ph1)-positive chronic myelocytic leukemia (CML) was studied during sequential phases of disease: (1) initial chronic phase; (2) myeloid blast crisis; (3) second chronic phase; and (4) accelerated diseas
Autor:
Martin J. Cline, HG Ahuja
Publikováno v:
Leukemia & Lymphoma. 4:153-158
(1991). Oncogenes and Anti-oncogenes in the Evolution of Human Leukemia/Lymphoma. Leukemia & Lymphoma: Vol. 4, No. 3, pp. 153-158.
Publikováno v:
Blood. 75:1684-1690
DNA from 161 patients with various forms of hematologic malignancies were investigated for mutations in exons 1 and 2 of the N-RAS, K-RAS and Ha-RAS gene by direct sequencing of DNA amplified in vitro by the polymerase chain reaction. Mutations invol
Publikováno v:
Blood. 75:819-822
At least 13 of 34 patients with acute myeloid leukemia (AML) of varying FAB types were heterozygous for a BamHI restriction fragment length polymorphism (RFLP) of the Ha-ras gene on chromosome 11. In 4 of these 13 patients, one allele of the Ha-ras g
Publikováno v:
British Journal of Haematology. 76:143-145
Alterations of the p53 anti-oncogene have recently been found to occur frequently in the blast crisis of chronic myelocytic leukaemia. The p53 gene may be altered by gross structural alterations or by point mutations in the coding sequence. We now re
Publikováno v:
Blood. 75(4)
At least 13 of 34 patients with acute myeloid leukemia (AML) of varying FAB types were heterozygous for a BamHI restriction fragment length polymorphism (RFLP) of the Ha-ras gene on chromosome 11. In 4 of these 13 patients, one allele of the Ha-ras g
Publikováno v:
British Journal of Haematology. 72:36-39
Summary. A novel mutation of the N-RAS gene of T-ALL blast cells was detected by a direct sequencing of in vitro amplified exon-1 of the N-RAS gene. Threonine (ACA) was substituted for alanine (GCA) at codon 11. This mutation would have been overlook
Publikováno v:
Proceedings of the National Academy of Sciences. 86:6783-6787
Molecular mechanisms responsible for the clinical progression of chronic myelocytic leukemia to its accelerated phase or to blast crisis have not been defined. We found alterations of the p53 gene (p53 is a 53-kDa nuclear protein) including deletions
Publikováno v:
Blood. 73:281-283
Mutations in codons 12 or 13 of the first exon of the N-RAS gene have been reported in myelodysplastic syndromes (MDS) in frequencies that vary between 9% and 40% depending on the techniques used in analysis. Gene amplification and direct sequencing